50 results
6-K
EX-99.1
PBM
Psyence Biomedical Ltd. Warrant
20 Sep 24
Share Purchase and Sale Agreement
5:00pm
traded company on the NASDAQ duly incorporated in Ontario, Canada;
"Sale Claims" means all amounts of any nature whatsoever owing by the Company
6-K
EX-99.2
PBM
Psyence Biomedical Ltd. Warrant
20 Sep 24
Share Purchase and Sale Agreement
5:00pm
pharmaceutical-grade, EU GMP nature-derived (non-synthetic) psilocybin to be evaluated in future clinical trials as a potential treatment for Alcohol … Use Disorders, we will look to PsyLabs for consistent supply of high-purity, nature-derived psilocybin that will best position us for long-term success
6-K
EX-99.1
PBM
Psyence Biomedical Ltd. Warrant
13 Sep 24
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
5:00pm
first life science biotechnology company focused on the development of botanical (nature-derived and non-synthetic) psilocybin-based psychedelic … -based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health
6-K
EX-99.2
PBM
Psyence Biomedical Ltd. Warrant
5 Sep 24
Current report (foreign)
4:31pm
Exhibit 99.2
Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated … -grade, EU GMP nature-derived (non-synthetic) psilocybin to be evaluated in future clinical trials as a potential treatment for AUD and other SUDs
6-K
EX-99.1
PBM
Psyence Biomedical Ltd. Warrant
5 Sep 24
Current report (foreign)
4:31pm
) or common law principle (including trade secret law and law relating to information of the same or similar nature and protected in the same or similar … as "Confidential," "Proprietary," or contains some similar designation, or which by its nature the receiving party knew or should have reasonably known
6-K
EX-99.1
kvm4rez ug431lsj
30 Aug 24
Current report (foreign)
4:06pm
424B3
5rl1d2hwfmxl4cq
30 Aug 24
Prospectus supplement
4:00pm
F-1
88awpqk3v
19 Aug 24
Registration statement (foreign)
4:07pm
F-1
EX-10.22
rjq9xp wd9
19 Aug 24
Registration statement (foreign)
4:07pm
424B3
k0ljtyg
19 Aug 24
Prospectus supplement
9:27am
POS AM
rc6cjwl
12 Aug 24
Prospectus update (post-effective amendment)
5:23pm
6-K
EX-99.3
vvzw8t
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
EX-99.1
xag3keezihp rvp2
31 Jul 24
Common Stock Purchase Agreement
4:11pm